Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Bartels

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 12, 2018
IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-γ/IRF-1 pathwayJohn R Klune, Christian Bartels, Jing Luo, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 7, 2016
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patientsIvan Demin, Christian Bartels, Gordon Graham, et al.
Technology in Cancer Research & Treatment|March 19, 2005
Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiationIrina V Larina, B Mark Evers, Taras V Ashitkov, et al.
Pulmonary Pharmacology & Therapeutics|July 30, 2021
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthmaRoland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
Pulmonary Pharmacology & Therapeutics|April 15, 2022
Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068]Roland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
Pulmonary Pharmacology & Therapeutics|December 27, 2017
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary diseaseJames F Donohue, Paul W Jones, Christian Bartels, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 5, 2021
Estimands-What they are and why they are important for pharmacometriciansMouna Akacha, Christian Bartels, Björn Bornkamp, et al.
Pulmonary Pharmacology & Therapeutics|May 11, 2020
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthmaRoland Buhl, Ana-Maria Tanase, Motoi Hosoe, et al.
American Journal of Respiratory and Critical Care Medicine|July 6, 2023
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical TrialFernando J Martinez, Gerard J Criner, Christian Gessner, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 12, 2018
IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-γ/IRF-1 pathwayJohn R Klune, Christian Bartels, Jing Luo, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 7, 2016
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patientsIvan Demin, Christian Bartels, Gordon Graham, et al.
Technology in Cancer Research & Treatment|March 19, 2005
Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiationIrina V Larina, B Mark Evers, Taras V Ashitkov, et al.
Pulmonary Pharmacology & Therapeutics|July 30, 2021
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthmaRoland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
Pulmonary Pharmacology & Therapeutics|April 15, 2022
Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068]Roland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
Pulmonary Pharmacology & Therapeutics|December 27, 2017
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary diseaseJames F Donohue, Paul W Jones, Christian Bartels, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 5, 2021
Estimands-What they are and why they are important for pharmacometriciansMouna Akacha, Christian Bartels, Björn Bornkamp, et al.
Pulmonary Pharmacology & Therapeutics|May 11, 2020
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthmaRoland Buhl, Ana-Maria Tanase, Motoi Hosoe, et al.
American Journal of Respiratory and Critical Care Medicine|July 6, 2023
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical TrialFernando J Martinez, Gerard J Criner, Christian Gessner, et al.
Pageof 2